Clinical Trials - Medika Life

Early, in-hospital treatment with colchicine reduces the odds of future cardiovascular problems by 48% in people who have just survived a heart attack

Forget Hype – Digital Therapeutic Data Show the Category Can be Held to High Clinical Standards

Gil Bashe, Medika Life Editor - September 4, 2024

New Study Points to a Strong Possibility that Digital Health Can Advance Migraine Care Treatment

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI is Transforming Health Delivery: A Five-Year Reflection

Forget Hype – Digital Therapeutic Data Show the Category Can be Held to High Clinical Standards

The Defining Dance Between Empathy and GenAI in Health

It’s Time for New Tools to Overcome Smoking

LATEST

TRENDING

Health Possibilities We Can’t Afford to Block

Texas: Endometriosis Clinical Study Participants – Women’s Health

AI is Transforming Health Delivery: A Five-Year Reflection

Texas: Migraine Clinical Study Participants – Men and Women

Tech Marches On, While Humanity Drags Its Feet

Four Ways COVID has Changed Health Tech

Covid’s Elephant in the Room. We Must Address it

Doctors Find Drug for Lethal Lung Disease After Decades of Trying

It’s Time for New Tools to Overcome Smoking

Texas: Hot Flashes Clinical Study Participants – Women’s Health

EDITORS CHOICE

Texas: Vaccine Clinical Study Participants – Men and Women

INOVIO’s COVID-19 Vaccine Shows Durable Antibody and T Cell Responses

Colchicine Shows 48% Reduction in Future Cardio Issues for Heart Attack Victims

Forget Hype – Digital Therapeutic Data Show the Category Can be Held to High Clinical Standards

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories